113
Views
6
CrossRef citations to date
0
Altmetric
Articles

Platelet growth factors suppress ex vivo expansion and enhance differentiation of umbilical cord blood CD133+ stem cells to megakaryocyte progenitor cells

, , &
Pages 409-416 | Received 18 Apr 2010, Accepted 24 Jun 2010, Published online: 21 Sep 2010

References

  • Baj-Krzyworzeka M, Majka M, Pratico D, Ratajczak J, Vilaire G, Kijowski J, Reca R, Janowska-Wieczorek A, Ratajczak MZ. 2002. Platelet-derived microparticles stimulate proliferation, survival, adhesion, and chemotaxis of hematopoietic cells. Exp Hematol. 30:450–459.
  • Bertolini F, Lazzari L, Lauri E. 1995. Comparative study of different procedures for the collection and banking of umbilical cord blood. J Hematother Stem Cell Res. 4:29–36.
  • Bradford M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 72:248–254.
  • Bruserud Ø, Foss B, Abrahamsen JF, Gjertsen BT, Ernst P. 2000. Autologous stem cell transplantation as post-remission therapy in adult acute myelogenous leukemia: Does platelet contamination of peripheral blood mobilized stem cell grafts influence the risk of leukemia relapse?. J Hematother Stem Cell Res. 9:433–443.
  • De Wynter EA. 2003. What is the future for cord blood stem cells?. Cytotechnology. 41:133–138.
  • Dercksen MW, Weimar IS, Richel DJ, Breton-Gorius J, Vainchenker W, Slaper-Cortenbach CM, Pinedo HM, von dem borne AE, Gerritsen WR, van der schoot CE. 1995. The value of flow cytometric analysis of platelet glycoprotein expression of CD34+ cells measured under conditions that prevent P-selectin-mediated binding of platelets. Blood. 86:3771–3782.
  • Doucet C, Ernou I, Zhang Y, Llense JR, Begot L, Holy X, Lataillade JJ. 2005. Platelet lysates promote mesenchymal stem cell expansion: A safety substitute for animal serum in cell-based therapy applications. JCP. 9999:1–9.
  • Fargeas CA, Fonseca AV, Huttner WB, Corbeil WB. 2006. Prominin-1 (CD133): From progenitor cells to human diseases. Future Lipidol. 1:213–225.
  • Fargeas CA, Huttner WB, Corbeil WB. 2007. Nomenclature of prominin-1 (AC133) splice variants- an updates. Tissue Antigens. 69:602–606.
  • Feng R, Shimazaki C, Inaba T, Takahashi R, Hirai H, Kikuta T, Sumikuma T, Yamagata M, Ashihara E, Fujita N. 1998. CD34/CD41a+ cells best predict platelet recovery after autologous peripheral blood stem cell transplantation. Bone Marrow Transplant. 21:1217–1222.
  • Foss B, Abrahamsen JF, Bruserud Ø. 2001. Peripheral blood stem cell grafts contain high levels of platelet-secreted mediators. Transfusion. 41:1431–1437.
  • Foss B, Bruserud Ø, Hervig T. 2008. Platelet-released supernatants enhance hematopoietic stem cell proliferation in vitro. Platelets. 19 2: 155–159.
  • Gluckman E. 2001. Hematopietic-stem cell transplants using umbilical-cord blood. N Engl J Med. 344:1860–1861.
  • Gluckman E, Rocha V, Boyer-Chammard A, Locatelli F, Arcese W, Pasquini R, Ortega J, Souillet G, Ferreira E, Laporte JP, Fernandez M, Chastang C. 1997. Outcome of cord blood transplantation from related and unrelated donors. N Engl J Med. 337:373–381.
  • Goodarzi A, Kheirandish M, Pourfathollah A. 2007. Characterization of Megakaryocyte Progenitor Cells Differentiated from Umbilical Cord Blood CD133+ and CD133– Cells. Yakhteh Med J. 9:190–195.
  • Graziani F, Ivanovski S, Cei S, Ducci F, Tonetti M, Gabriele M. 2006. The in vitro effect of different PRP concentrations on osteoblasts and fibroblasts. Clin Oral Imp Res. 17:212–219.
  • Gutensohn K, Bartsch N, Kuehnl P. Flow cytometric analysis of platelet membrane antigens during and after continuous-flow plateletpheresis. Transfusion. 1997a; 37:809–815.
  • Gutensohn K, Maerz M, Kuehnl P. Alteration of platelet-associated membrane glycoproteins during extracorporeal apheresis of peripheral blood progenitor cells. J Hematother. 1997b; 6:315–321.
  • Han Z C, Sensebe L, Abgrall J F, Brieve J. 1990. Platelet factor 4 inhibits human megakaryopoiesis in vitro. Blood. 75:1234–1239.
  • Harris D. 2008. Collection, processing, and banking of umbilical cord blood stem cells for clinical use in transplantation and regenerative medicine. Lab Med. 39:173–178.
  • Kaps C, Loch A, Haisch A. 2002. Human platelet supernatant promotes proliferation but not differentiation of articular chondrocytes. Med Biol Eng Comput. 40:485–490.
  • Kaushansky K, Broudy VC, Lin N, Jorgensen MJ, McCarty J, Fox N, Zucker-Franklin D, Lofton-Day C. 1995. Thrombopoietin, the Mpl ligand, is essential for full megakaryocyte development. Proc Natl Acad Sci USA. 92:3234–3238.
  • Keler JR, Mcniece AK, Sill KT. 1990. Transforming growth factor β directly regulates primitive murine hematopoietic cell proliferation. Blood. 75:596–602.
  • Kilian O, Flesch I, Wenisch S, Taborski B, Jork A, Schnettler R, Jonuleit T. 2004. Effects of Platelet Growth Factors on Human Mesenchymal Stem Cells and Human Endothelial Cells In vitro. Eur J Med Res. 9:337–344.
  • Kleinman S, Chan P, Robillard P. 2003. Risks Associated With Transfusion of Cellular Blood Components in Canada. Transfus Med Rev. 17:120–162.
  • Kogler G, Nurnberger W, Fischer J, Niehues T, Somville T, Gobel U. 1999. Simultaneous cord blood transplatelet Lysate annotation of ex vivo expanded together with non-ex vivo expanded cells for high risk leukemia. Bone Marrow Transplant. 24:397–403.
  • Kuter D, Gminski D, Rosenberg R. 1992. Transforming growth factor β inhibits megakaryocyte growth and endomitosis. Blood. 79:619–625.
  • Lam AC, Li K, Zhang XB, Li CK, Fok TF, Chang AM, James AE, Tsang KS, Yuen PM. 2001. Preclinical ex vivo expansion of cord blood hematopoietic stem and progenitor cells: During of culture; the media, serum supplements, and growth factor used; and engraftment in NOD/SCID mice. Transfusion. 41:1567–1576.
  • Liu J, Li K, Yuen PM, Fok TF, Yau FW, Yang M, Li CK. 1999. Ex vivo expansion of enriched CD34+ cells from neonatal blood in the presence of thrombopoietin, a comparison with cord blood and bone marrow. Bone Marrow Transplant. 24:247–252.
  • Lucarelli E, Beccheroni A, Donati D. 2003. Platelet derived growth factors enhance proliferation of human stromal stem cells. Biomaterials. 24:3095–3310.
  • Martieau I, Lacoste E, Gagnon G. 2004. Effects of calcium and thrombin on growth factor release from platelet concentrates: Kinetics and regulation of endothelial cell proliferation. Biomaterials. 25:4489–4502.
  • Marx RE. 2004. Platelet-rich plasma: Evidence to support its use. Am Assoc Oral Maxillofac Surg. 62:489–496.
  • Miltenyi S. 1997. CD34+ Selection: The Basic Component for Graft Engineering. Oncologist. 2:410–413.
  • Ogino Y, Ayukawa Y, Kukita T. 2006. Transforming Growth factor-β1, and Insulin-like Growth Factor-1 in Platelet Rich Plasma to the Proliferation of Osteoblast-like Cells. Oral Surg Oral Med. 101:724–729.
  • Pasino M, Lanza T, Marotta F, Scarso L, De Biasio P, Amato S, Corcione A, Pistoia V, Mori PG. 2000. Flow cytometric and functional characterization of AC133+ cells from umbilical cord blood. Br J Hematol. 108:793–800.
  • Pecora AL, Stiff P, Jennis A, Goldberg S, Rosenbluth R, Price P, Goltry KL, Douville J, Armstrong RD, Smith AK, Preti RA. 2000. Prompt and durable engraftment in two older adult patients with high risk chronic myelogenous leukemia (CML) using ex vivo expanded and unmanipulated unrelated umbilical cord blood. Bone Marrow Transplant. 25:797–799.
  • Piacibello P, Sanavio F, Severino A, Dane A, Gmaitoni L, Fagioli F, Perissinotto E, Cavalloni G, Kollet O, Lapidot T, Aglietta M. 1999. Engraftment in nonobese diabetic severe combined immunodeficiency mice of human CD34 (+) cord blood cells after ex vivo expansion: Evidence for the application and self-renewal repopulating stem cells. Blood. 93:3736–3749.
  • Pranke PJ, Hendrikx Debnath G, Alespeiti G, Rubinstein P, Nardi N, Visser J. 2005. Immunophenotype of hematopoietic stem cells from placental/umbilical cord blood after culture. Braz J Med Biol Res. 38:1775–1789.
  • Reddy NP, Vemuri MC, Pallu R. 2007. Isolation of stem cells from human umbilical cord blood. Methods Mol Biol. 407:149–163.
  • Rocha V, Cornish J, Sievers EL, Filipovich A, Locatelli F, Peters C, Remberger M, Michel G, Arcese W, Dallorso S, Tiedemann K, Busca A, Chan KW, Kato S, Ortega J, Vowels M, Zander A, Souillet G, OaKll A, Woolfrey A, Pay AL, Green A, Garnier F, Ionescu I, Wernet P, Sirchia G, Rubinstein R, Chevret S, Gluckman G. 2001. Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia. Blood. 97:2962–2971.
  • Rubinstein P. 2006. Why cord blood?. Human Immunology. 67:398–404.
  • Rubinstein P, Carrier C, Scaradavou A, Kurtsberg J, Adamson J, Migliaccio AR, Berkowitz RL, Cabbad M, Dobrila NL, Taylor PE, Rosenfield RE, Stevens CE. 1998. Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N Engl J Med. 339:1565–1577.
  • Saigo K, Kumagai S, Sugimoto T, Matsui T, Ryo R. 2001. RANTES and p-Selectin in peripheral blood stem. Ther Apher Dial. 5:517–518.
  • Schallmoser K, Bartmann C, Rohde E, Reainisch A, Kashofer K, Stadelmeyer E, Drexler C, Lanzer G, Linkesch W, Strunk D. 2007. Human platelet lysate can replace fetal bovine serum for clinical-scale expansion of functional mesenchymal stromal cells. Transfusion. 47:1436–1446.
  • Schmid I, Uittenbogaart CH, Krall WJ, Braun J, Giorgi JV. 1992. Dead cell discrimination with 7-amino-actinomycin D in combination with dual color immunofluorescence in single laser flow cytometry. Cytometry. 13:204–208.
  • Skoric D, Balint B, Petakov M. 2007. Collection strategies and cryopreservation of umbilical cord blood. Transfus Med. 17:107–113.
  • Stroncek DF, Clay ME, Smith J, Herr G, Ilstrup SJ, Kunkel LA, McCullough J. 1997. Composition of peripheral blood progenitor cell components collected from a healthy donors. Transfusion. 37:411–417.
  • Stroncek DF, Clay ME, Jaszcz W, Lennon S, Smith J, McCullough J. 1999. Collection of two peripheral blood stem cell concentrates from healthy donors. Transfus Med. 9:37–50.
  • Su RJ, Li K, Yang M, Zhang XB, Tsang KS, Fok TF, Li CK, Yuen PMP. 2001. Platelet – derived growth factor enhances ex vivo expansion of megakaryocytic progenitors from human cord blood. Bome Marrow Transplantat. 27:1075–1080.
  • Sundell B, Cheung EN, Terry D, Sheridan W. 2000. Effects of megakaryocyte growth and development factor on platelet production, platelet life span, and platelet function in healthy human volunteers. Blood. 95:8.
  • Tan KK, Tang KZ, Huang S. 2007. Devices for umbilical cord blood collection. Recent Pat Eng. 1:89–94.
  • Tao H, Gaudry L, Rice A, Chong B. 1999. Cord blood is better than bone marrow for generation megakaryocytic progenitor cells. Exp Hematol. 27:293–301.
  • Vladareanu AM, Mihailescu D, Tudosa R, Zvanca M, Vladareanu R. 2007. Cord blood stem cells. Where do we stand?. J Clin Med. 2:142–152.
  • Voss R, Scarlat T, Matzdorff A, Tillmanns H. 1996. Flow cytometric detection of platelet activation in patients undergoing diagnostic and interventional coronary angiography. Platelets. 7:237–241.
  • Yang Mo, Chesterman CN, Chong BH. 1995. Recombinant PDGF enhances megakaryocytopoiesis in vitro. Br J Hematol. 91:285–289.
  • Yoo ES, Ryu KH, Park HY, Seong CM, Chung WS, Kim SC, Choi YM, Hahn MJ, Woo SY, Seoh JY. 1999. Myeloid differentiation of human cord blood CD34+ cells during ex vivo expansion using thrombopoietin, flt3-ligand and/or granulocyte-colony stimulating factor. Br J Hematol. 105:1034–1040.
  • Zimmermann R, Arnold D, Strasser E, Ringwald J, Schlegel A, Wiltfang J, Eckstein R. 2003. Sample preparation technique and white cell content influence the detectable levels of growth factors in platelet concentrates. Vox Sang. 85:283–289.
  • Zimmermann R, Jakubietz R, Jakubietz M, Strasser E, Schlegel A, Wiltfang J, Eckstein R. 2001. Different preparation methods to obtain platelet components as a source of growth factors for local application. Transfusion. 41:1217–1224.
  • Zingsem J, Glaser A, Weisbach V. 1998. Evaluation of a platelet apheresis technique for the preparation of leukocyte-reduced platelet concentrates. Vox Sang. 74:189–192.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.